GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Bioscience Animal Health PCL (BKK:BIS) » Definitions » YoY EBITDA Growth

Bioscience Animal Health PCL (BKK:BIS) YoY EBITDA Growth : 71.43% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Bioscience Animal Health PCL YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Bioscience Animal Health PCL's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 71.43%.

Bioscience Animal Health PCL's EBITDA per Share for the three months ended in Mar. 2024 was ฿0.07.


Bioscience Animal Health PCL YoY EBITDA Growth Historical Data

The historical data trend for Bioscience Animal Health PCL's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioscience Animal Health PCL YoY EBITDA Growth Chart

Bioscience Animal Health PCL Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial 658.33 -15.38 17.86 -4.96 -21.74

Bioscience Animal Health PCL Quarterly Data
Dec17 Dec18 Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -54.84 -25.32 8.00 22.22 71.43

Bioscience Animal Health PCL YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Bioscience Animal Health PCL's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(0.27-0.345)/ | 0.345 |
=-21.74 %

Bioscience Animal Health PCL's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(0.072-0.042)/ | 0.042 |
=71.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioscience Animal Health PCL YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Bioscience Animal Health PCL's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioscience Animal Health PCL (BKK:BIS) Business Description

Traded in Other Exchanges
N/A
Address
Bond Street Road, No. 479, 4th Floor, Muangthongthani, Bangphut, Pakkret, Nonthaburi, THA, 11120
Bioscience Animal Health PCL engaged in manufacture, import and distribution of pharmaceutical supplies, medical devices, equipment, and products for livestock and companion animals (pets). Geographically, the company generates revenue from Thailand.

Bioscience Animal Health PCL (BKK:BIS) Headlines